Morgan Stanley analyst Craig Hettenbach reiterated an Equalweight rating and $60.00 price target on Hims and Hers (NYSE: HIMS)The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Hims and Hers (HIMS) PT Raised to $39 at Truist SecuritiesFebruary 26, 2025 5:30 AM Hims and Hers (HIMS) PT Raised to $61 at NeedhamFebruary 25, 2025 6:07 AM Leerink Partners Reiterates Market Perform Rating on Hims and Hers (HIMS)February 25, 2025 5:36 AM Truist Securities Reiterates Hold Rating on Hims and Hers (HIMS)February 25, 2025 5:34 AM BofA Securities Reiterates Underperform Rating on Hims and Hers (HIMS), PT $21February 25, 2025 5:17 AM BTIG Reiterates Buy Rating on Hims and Hers (HIMS)February 25, 2025 5:11 AM Nephron Downgrades Hims and Hers (HIMS) to HoldFebruary 25, 2025 5:00 AM Hims and Hers (HIMS) PT Raised to $27 at Citi, Maintains Sell 'as we await a better entry point and more details on growth outside GLP-1s'February 25, 2025 4:58 AM After-hours movers: Zoom, Hims & Hers Health, Tempus AI, and moreFebruary 24, 2025 4:50 PM Hims&Hers Health Q4 earnings fall short of estimatesFebruary 24, 2025 4:29 PM Hims & Hers Health, Inc. (HIMS) Misses Q4 EPS by 6c, Revenue Beats, Offers GuidanceFebruary 24, 2025 4:08 PM Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial ResultsFebruary 24, 2025 4:05 PM Hims & Hers earnings preview: BofA weighs in ahead of the reportFebruary 24, 2025 12:00 PM Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1.1 puts into quarter results and outlookFebruary 24, 2025 10:47 AM Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1 put on active volume into quarter resultsFebruary 24, 2025 4:59 AM Piper Sandler Reiterates Neutral Rating on Hims and Hers (HIMS), PT $24February 21, 2025 12:23 PM Analysts explain why Hims & Hers stock is crashing todayFebruary 21, 2025 11:41 AM Hims & Hers Health, Inc. (HIMS) call put ratio 1.1 calls to 1 put amid wide price movement into quarter resultsFebruary 21, 2025 11:01 AM Today's FDA news a 'clear negative' for Hims and Hers (HIMS) - BofA SecuritiesFebruary 21, 2025 10:29 AM Novo's Wegovy and Ozempic removed from US FDA shortage list, compounders on noticeFebruary 21, 2025 9:16 AM Hims & Hers Health, Inc. (HIMS) Weakness Tied to Report FDA Says Ozempic, Wegovy Shortage Resolved February 21, 2025 9:13 AM Hims & Hers Health (HIMS) Acquires Peptide FacilityFebruary 21, 2025 9:00 AM Hims & Hers Acquires US-based Peptide FacilityFebruary 21, 2025 9:00 AM Hims & Hers Health, Inc. (HIMS) call put ratio 1.2 calls to 1 put into quarter resultsFebruary 21, 2025 6:19 AM